Mathias Holsey Gramkow
Overview
Explore the profile of Mathias Holsey Gramkow including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
26
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Clemmensen F, Gramkow M, Simonsen A, Ashton N, Huber H, Blennow K, et al.
Alzheimers Res Ther
. 2025 Jan;
17(1):26.
PMID: 39838483
Background: For clinical implementation of Alzheimer's disease (AD) blood-based biomarkers (BBMs), knowledge of short-term variability, is crucial to ensure safe and correct biomarker interpretation, i.e., to capture changes or treatment...
2.
Gleerup H, Simonsen A, Grotschel L, Gramkow M, Hogh P, Blennow K, et al.
Alzheimers Dement (Amst)
. 2025 Jan;
17(1):e70073.
PMID: 39822295
Introduction: Studies have shown that blood biomarkers can differentiate dementia disorders. However, the diagnosis of dementia still relies primarily on cerebrospinal fluid and imaging modalities. The new disease-modifying treatments call...
3.
Gramkow M, Waldemar G, Frederiksen K
Nat Rev Neurol
. 2024 Oct;
20(12):738-746.
PMID: 39455807
Several major challenges, including an ageing population and declining workforce and the implementation of recent breakthrough therapies for Alzheimer disease, are prompting a necessary rethink of how people with neurodegenerative...
4.
Gramkow M, Clemmensen F, Sjaelland N, Waldemar G, Hasselbalch S, Frederiksen K
Alzheimers Dement (Amst)
. 2024 Aug;
16(3):e12628.
PMID: 39086497
Highlights: We demonstrated the diagnostic performance of qLRP in Alzheimer's disease.The diagnostic models were robust in sensitivity analyses.qLRP may assist in the bedside diagnostic evaluation of Alzheimer's disease.
5.
Gramkow M, Clemmensen F, Waldemar G, Hasselbalch S, Frederiksen K
J Neurol Sci
. 2023 Dec;
456:122856.
PMID: 38154247
Background: Quantitative light reflex pupillometry (qLRP) may be a promising digital biomarker in neurodegenerative diseases such as Alzheimer's disease (AD), as neuropathological changes have been found in the midbrain structures...
6.
Gramkow M, Damsgaard L, McWilliam O, Roos P
Ugeskr Laeger
. 2023 Dec;
185(50).
PMID: 38084624
Introduction Christmas-themed scientific articles are becoming increasingly popular and may represent a shortcut to scientific demise due to their demand for time better spent on "serious" research. We aimed to...
7.
Gramkow M, Simonsen A, Hasselbalch S, Waldemar G, Frederiksen K
Int J Geriatr Psychiatry
. 2023 Jul;
38(7):e5968.
PMID: 37458494
Background: It has been shown under experimental conditions that cognitive performance, especially working memory, is impaired in patients with type I and type II diabetes mellitus during hyperglycemic and hypoglycemic...
8.
Dimopoulos K, Simonsen A, Gramkow M, Schroder M, Jorgensen N, Rode L, et al.
Clin Chem Lab Med
. 2023 Mar;
61(9):e182-e185.
PMID: 36999396
No abstract available.
9.
McWilliam O, Gramkow M, Roos P, Vogel A
Ugeskr Laeger
. 2022 Dec;
184(50).
PMID: 36510809
Introduction Motivation is important when administering cognitive tests. Routine cognitive testing may become trivial both for the examiner and the test subject when using tests that only incorporate neutral items....
10.
Gusatovic J, Gramkow M, Hasselbalch S, Frederiksen K
PeerJ
. 2022 Jul;
10:e13604.
PMID: 35846877
Introduction: Aerobic exercise interventions may affect different cognitive domains such as attention, working memory, inhibition, . However, the neural mechanisms underlying this relationship, remains uncertain. Objective: To perform a systematic...